Skip to content
OpenCapital
Get started

Greenwich LifeSciences GLSI Q3 2024 earnings

Reported November 14, 2024 · Before market open

Diluted EPS-$0.20Beat by $0.01
EPS estimate-$0.21

Next report

Aug 13, 2026 (in a month)
EPS estimate-$0.34

Versus estimates

Revenue

Q4 2024$3.6K

Diluted EPS

Q1 2026-$0.39Miss by $0.06Q3 2025-$0.30In lineQ2 2025-$0.30Miss by $0.06Q1 2025-$0.25Miss by $0.01Q4 2024-$0.61Miss by $0.40
Q3 2024-$0.20Beat by $0.01

Ask the moment Greenwich LifeSciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Greenwich LifeSciences report Q3 2024 earnings?
Greenwich LifeSciences (GLSI) reported Q3 2024 earnings on November 14, 2024 before market open.
What were Greenwich LifeSciences's Q3 2024 revenue and EPS?
Greenwich LifeSciences reported diluted EPS of $-0.20 for Q3 2024.
Did Greenwich LifeSciences beat estimates in Q3 2024?
EPS beat the consensus estimate of $-0.21 by $0.01.
Where can I find Greenwich LifeSciences's Q3 2024 SEC filings?
You can read the 10-Q periodic report (0001493152-24-045938) directly on SEC EDGAR. The filing index links above go to sec.gov.